Influence of growth hormone on accretion of bone mass
- PMID: 12373015
- DOI: 10.1159/000064765
Influence of growth hormone on accretion of bone mass
Abstract
Growth hormone (GH) exerts important influences on bone metabolism during lifespan. During childhood, GH is a major determinant of acquisition of bone mass and in adult life, GH partly determines the rate of bone remodelling and therefore influences maintenance of bone mineral density (BMD). Insights into the importance of GH in these respects may be obtained by studies of BMD and indices of bone remodelling in GH deficiency (GHD) of adult-onset and childhood-onset. Adult-onset GHD, usually accompanied by other features of hypopituitarism, may be associated with osteopenia and an increased fracture risk. Postulated mechanisms include GHD and gonadal steroid deficiency of unknown duration; glucocorticoid and thyroxine replacement do not appear to exert a major role. GH replacement in adult-onset GHD results in an early increment in indices of bone remodelling which persists for up to 5 years; BMD increases by 0.5-1.0 SD in males and stabilizes in females over this time period. In adolescents with GHD who traditionally discontinue GH at completion of linear growth, BMD is substantially lower than peak bone mass for a young adult population. Studies addressing the effects of continuation of GH after achievement of final height are currently underway and will provide insights into the possible need to continue GH into adult life. Such studies may confirm a role for GH in promoting continued accrual of bone mass and thereby demonstrate that cessation of GH at achievement of final height, by limiting peak bone mass, may predispose to clinically significant osteoporosis in later life. In addition to the potential importance of GH for achievement of peak bone mass, there may be a superimposed accelerated loss of BMD with advancing age similar to the situation observed in adult-onset GHD. To date, this has been difficult to assess in adult GHD of childhood-onset because the relative contributions of low peak bone mass and increased loss of bone in later life could not be distinguished.
Copyright 2002 S. Karger AG, Basel
Similar articles
-
Skeletal requirements for optimal growth hormone replacement in the transitional years.Growth Horm IGF Res. 2003 Aug;13 Suppl A:S130-5. doi: 10.1016/s1096-6374(03)00069-8. Growth Horm IGF Res. 2003. PMID: 12914741 Review.
-
The effect of cessation of growth hormone (GH) therapy on bone mineral accretion in GH-deficient adolescents at the completion of linear growth.J Clin Endocrinol Metab. 2003 Apr;88(4):1658-63. doi: 10.1210/jc.2002-021541. J Clin Endocrinol Metab. 2003. PMID: 12679453 Clinical Trial.
-
Growth hormone and bone health.Horm Res. 2003;60 Suppl 3:80-6. doi: 10.1159/000074507. Horm Res. 2003. PMID: 14671403 Review.
-
The influence of gender on the short and long-term effects of growth hormone replacement on bone metabolism and bone mineral density in hypopituitary adults: a 5-year study.Clin Endocrinol (Oxf). 2001 Apr;54(4):525-32. doi: 10.1046/j.1365-2265.2001.01246.x. Clin Endocrinol (Oxf). 2001. PMID: 11318789
-
Skeletal effects of two years of treatment with low physiological doses of recombinant human growth hormone (GH) in patients with adult-onset GH deficiency.J Clin Endocrinol Metab. 1998 Jun;83(6):2143-8. doi: 10.1210/jcem.83.6.4851. J Clin Endocrinol Metab. 1998. PMID: 9626153 Clinical Trial.
Cited by
-
Effects of Cushing disease on bone mineral density in a pediatric population.J Pediatr. 2010 Jun;156(6):1001-1005. doi: 10.1016/j.jpeds.2009.12.027. Epub 2010 Mar 10. J Pediatr. 2010. PMID: 20223476 Free PMC article.
-
Impact of depression and its treatment on the bones of growing children.Curr Psychiatry Rep. 2007 Apr;9(2):94-8. doi: 10.1007/s11920-007-0077-8. Curr Psychiatry Rep. 2007. PMID: 17389117
-
Systematic Review: Does Exercise Training Influence Ghrelin Levels?Int J Mol Sci. 2025 May 15;26(10):4753. doi: 10.3390/ijms26104753. Int J Mol Sci. 2025. PMID: 40429895 Free PMC article.
-
The exon 3 polymorphism of the growth hormone receptor is a severity-related factor for osteoporosis.Endocrine. 2014 Apr;45(3):487-96. doi: 10.1007/s12020-013-0004-1. Epub 2013 Jun 28. Endocrine. 2014. PMID: 23812803
-
Exercise for optimizing bone health after hormone-induced increases in bone stiffness.Front Endocrinol (Lausanne). 2023 Sep 18;14:1219454. doi: 10.3389/fendo.2023.1219454. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37790607 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical